• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛糖还原酶抑制剂唑泊司他在大鼠体内的组织分布及生物转化

Tissue distribution and biotransformation of zopolrestat, an aldose reductase inhibitor, in rats.

作者信息

Schneider R P, Fouda H G, Inskeep P B

机构信息

Drug Metabolism Department, Central Research Division, Pfizer Inc., Groton, CT 06340, USA.

出版信息

Drug Metab Dispos. 1998 Nov;26(11):1149-59.

PMID:9806959
Abstract

Zopolrestat (Alond) is a new drug that is being evaluated as an aldose reductase inhibitor for the treatment of diabetic complications. 14C-labeled zopolrestat was orally administered to rats for a tissue distribution study and a bile duct cannulation metabolism study. Tissue samples from the distribution study were analyzed by complete oxidation and liquid scintillation counting. Urine and bile samples from the bile duct cannulation study were analyzed by microbore HPLC, with simultaneous radioactivity monitoring and atmospheric pressure ionization tandem mass spectrometry. The mass balance in the distribution study demonstrated that the greatest exposure (AUC0-infinity) occurred in the liver, followed by the ileum and large intestine. The time of maximal plasma concentrations for nearly all tissues was 4 hr after the dose, and the half-life of radioactivity in most tissues (8-10 hr) was similar to the half-life in plasma. For the bile duct-cannulated rat study, most of the radioactivity was recovered in the bile, indicating that biliary excretion is a major route of elimination of zopolrestat and its metabolites in rats. Numerous oxidative metabolites, as well as phase II conjugates, were identified in the bile and urine samples. Acyl glucuronides of zopolrestat and unchanged drug accounted for >85% of biliary radioactivity, whereas unchanged drug and degradation products of glutathione conjugates were identified as the major urinary metabolites.

摘要

唑泊司他(Alond)是一种新型药物,正作为醛糖还原酶抑制剂进行评估,用于治疗糖尿病并发症。将14C标记的唑泊司他口服给予大鼠,进行组织分布研究和胆管插管代谢研究。分布研究的组织样本通过完全氧化和液体闪烁计数进行分析。胆管插管研究的尿液和胆汁样本通过微径高效液相色谱进行分析,同时进行放射性监测和大气压电离串联质谱分析。分布研究中的质量平衡表明,最大暴露量(AUC0-无穷大)出现在肝脏,其次是回肠和大肠。几乎所有组织的最大血浆浓度时间为给药后4小时,大多数组织中放射性的半衰期(8-10小时)与血浆中的半衰期相似。对于胆管插管大鼠研究,大部分放射性在胆汁中回收,表明胆汁排泄是唑泊司他及其代谢产物在大鼠体内的主要消除途径。在胆汁和尿液样本中鉴定出了许多氧化代谢产物以及II相缀合物。唑泊司他的酰基葡萄糖醛酸苷和未变化的药物占胆汁放射性的>85%,而未变化的药物和谷胱甘肽缀合物的降解产物被鉴定为主要的尿液代谢产物。

相似文献

1
Tissue distribution and biotransformation of zopolrestat, an aldose reductase inhibitor, in rats.醛糖还原酶抑制剂唑泊司他在大鼠体内的组织分布及生物转化
Drug Metab Dispos. 1998 Nov;26(11):1149-59.
2
Bioavailability, multiple-dose pharmacokinetics, and biotransformation of the aldose reductase inhibitor zopolrestat in dogs.
Drug Metab Dispos. 1998 Nov;26(11):1160-6.
3
Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.新型抗焦虑候选药物CP-93,393在长 Evans 大鼠体内的代谢与排泄。通过液相色谱/串联质谱法区分区域异构体葡糖醛酸苷。
Drug Metab Dispos. 1997 Nov;25(11):1288-97.
4
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.人白细胞弹性蛋白酶的口服活性抑制剂。I. L-683,845在大鼠和恒河猴体内的处置情况。
Drug Metab Dispos. 1996 Dec;24(12):1369-77.
5
Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.雄性小鼠体内碳-14标记的muraglitazar的生物转化:导致独特代谢物的代谢途径中的种间差异。
Drug Metab Dispos. 2006 May;34(5):807-20. doi: 10.1124/dmd.105.007856. Epub 2006 Feb 7.
6
Pharmacokinetics of the aldose reductase inhibitor, zopolrestat, in humans.醛糖还原酶抑制剂佐泊司他在人体中的药代动力学。
J Clin Pharmacol. 1994 Jul;34(7):760-6. doi: 10.1002/j.1552-4604.1994.tb02037.x.
7
Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.口服14C和3H标记的齐拉西酮混合物后,新型抗精神病药物齐拉西酮在大鼠体内的代谢和排泄。
Drug Metab Dispos. 1997 Feb;25(2):206-18.
8
Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats.羧酸醛糖还原酶抑制剂唑泊司他在正常大鼠和糖尿病大鼠体内的药代动力学
Pharm Res. 1991 Dec;8(12):1511-5. doi: 10.1023/a:1015894300247.
9
Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.利福喷汀(一种利福霉素类抗生素)在小鼠、大鼠和猴子体内的处置与代谢。
Drug Metab Dispos. 1998 Aug;26(8):725-31.
10
Metabolism and disposition of moxonidine in Fischer 344 rats.莫索尼定在费希尔344大鼠体内的代谢与处置
Drug Metab Dispos. 2000 Apr;28(4):446-59.

引用本文的文献

1
Physiological and Pathological Roles of Aldose Reductase.醛糖还原酶的生理和病理作用
Metabolites. 2021 Sep 27;11(10):655. doi: 10.3390/metabo11100655.
2
Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.维生素 K1 通过抑制晶状体醛糖还原酶 2(ALR2)活性预防糖尿病性白内障。
Sci Rep. 2019 Oct 11;9(1):14684. doi: 10.1038/s41598-019-51059-2.